Medtronic plc Stock
€82.04
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 0.950% | -0.750% | -9.518% | 6.476% | 6.476% | 12.941% | -12.621% |
| Dexcom Inc. | -0.420% | 1.093% | 4.541% | -24.079% | -24.079% | -44.895% | -21.264% |
| Henry Schein Inc. | 0.460% | 0.062% | 0.031% | -2.668% | -2.668% | -13.193% | 21.112% |
| Zimmer Holdings | 0.290% | 1.371% | -8.036% | -24.348% | -24.348% | -35.627% | -38.480% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
Most dividend investors are looking not just for a high yield, but also for a company that can reliably support that yield over the long term. It is harder to find than you may think, but not
Medtronic: A Strong Contender in the Medical Device Arena
Explore the exciting world of Medtronic (NYSE: MDT) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
A $1,000 investment will buy you nearly 20 shares of Bristol Myers Squibb (NYSE: BMY) and about 10 shares of Medtronic (NYSE: MDT). For dividend lovers, they should both be appealing buy-and-hold